Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangdi Li

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 27, 2019
Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatmentYali Wang, Erik De Clercq, Guangdi Li
Metabolism: Clinical and Experimental|June 6, 2021
Molecular mechanisms underlying hepatitis C virus infection-related diabetesYujin Ding, Guangdi Li, Zhiguang Zhou, et al.
Clinical, Cosmetic and Investigational Dermatology|December 17, 2024
Multi-Layer Tissue Injury of the Abdominal Wall Caused by Improper Treatment of Subcutaneous Hydrops After LiposuctionGuangdi Li, Guiwen Zhou, Qiang Fu, et al.
Environmental Science and Pollution Research International|September 8, 2016
Short-term contributions of cover crop surface residue return to soil carbon and nitrogen contents in temperate AustraliaXiaoqi Zhou, Hanwen Wu, Guangdi Li, et al.
Nutrients|July 9, 2022
Global Burden of Nutritional Deficiencies among Children under 5 Years of Age from 2010 to 2019Tingting Yue, Quanquan Zhang, Guangdi Li, et al.
IEEE Journal of Biomedical and Health Informatics|November 3, 2023
AntiViralDL: Computational Antiviral Drug Repurposing Using Graph Neural Network and Self-Supervised LearningPan Zhang, Xiaowen Hu, Guangdi Li, et al.
Drug Design, Development and Therapy|August 9, 2020
Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in TherapyMiao Miao, Xixi Jing, Erik De Clercq, et al.
Nature Reviews. Drug Discovery|April 19, 2023
Therapeutic strategies for COVID-19: progress and lessons learnedGuangdi Li, Rolf Hilgenfeld, Richard Whitley, et al.
Biochemical Pharmacology|February 22, 2021
Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De ClercqGuangdi Li, Ming Xu, Tingting Yue, et al.
Virus Genes|September 11, 2002
High-level expression of the C-terminal hydrophobic region of HCV E2 protein ectodomain in E. coliJing Liu, Yuying Kong, Lixin Zhu, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Metabolism & Toxicology|September 27, 2019
Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatmentYali Wang, Erik De Clercq, Guangdi Li
Metabolism: Clinical and Experimental|June 6, 2021
Molecular mechanisms underlying hepatitis C virus infection-related diabetesYujin Ding, Guangdi Li, Zhiguang Zhou, et al.
Clinical, Cosmetic and Investigational Dermatology|December 17, 2024
Multi-Layer Tissue Injury of the Abdominal Wall Caused by Improper Treatment of Subcutaneous Hydrops After LiposuctionGuangdi Li, Guiwen Zhou, Qiang Fu, et al.
Environmental Science and Pollution Research International|September 8, 2016
Short-term contributions of cover crop surface residue return to soil carbon and nitrogen contents in temperate AustraliaXiaoqi Zhou, Hanwen Wu, Guangdi Li, et al.
Nutrients|July 9, 2022
Global Burden of Nutritional Deficiencies among Children under 5 Years of Age from 2010 to 2019Tingting Yue, Quanquan Zhang, Guangdi Li, et al.
IEEE Journal of Biomedical and Health Informatics|November 3, 2023
AntiViralDL: Computational Antiviral Drug Repurposing Using Graph Neural Network and Self-Supervised LearningPan Zhang, Xiaowen Hu, Guangdi Li, et al.
Drug Design, Development and Therapy|August 9, 2020
Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in TherapyMiao Miao, Xixi Jing, Erik De Clercq, et al.
Nature Reviews. Drug Discovery|April 19, 2023
Therapeutic strategies for COVID-19: progress and lessons learnedGuangdi Li, Rolf Hilgenfeld, Richard Whitley, et al.
Biochemical Pharmacology|February 22, 2021
Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De ClercqGuangdi Li, Ming Xu, Tingting Yue, et al.
Virus Genes|September 11, 2002
High-level expression of the C-terminal hydrophobic region of HCV E2 protein ectodomain in E. coliJing Liu, Yuying Kong, Lixin Zhu, et al.
Pageof 10